Microenvironment Modulating Bispecific Antibodies (Zymeworks)

N/A

Report date: 2025/01/26 17:11:41

Base Information

Drug NameMicroenvironment Modulating Bispecific Antibodies (Zymeworks)

Drug Alias NameMicroenvironment Modulators (Zymeworks)anti-IL-12 bi-speific antibodies (Zymeworks)

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionInterleukin-12 modulators

TargetsInterleukin-12

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCanada

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesZymeworks Inc

China Registration ClassN/A

Develop Information

Active CompaniesZymeworks Inc

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsN/A

Other Information

ATC CodeN/A